HOME >> BIOLOGY >> NEWS
Changing global nitrogen cycle impacting human health, says Colorado University-led study

Despite greatly increasing food production for humans, the growing use of nitrogen as a nutrient is affecting people's health far beyond just the benefits of growing more crops, according to a new University of Colorado at Boulder-led study.

Study leader Alan Townsend of CU-Boulder's Institute for Arctic and Alpine Research said changes in the global nitrogen cycle, while beneficial in increasing crop growth, appear to pose a growing health risk. Roughly half of the inorganic nitrogen ever used on the planet has occurred in the past 15 years.

An obvious, positive aspect of using nitrogen as a fertilizer has been a huge increase in food production in poor nations, reducing hunger and malnutrition, he said. Although nitrogen is the most abundant of Earth's atmospheric gases, it must be converted to chemically usable forms like nitrate or ammonium. In the absence of humans, this happens during lightning strikes or more commonly through microbes.

"The major global changes in the nitrogen cycle have occurred because humans now convert more nitrogen to such usable forms than all natural processes combined," he said. "The synthesis of nitrogen fertilizers accounts for most of this change. But the overuse of nitrogen fertilizers can lead to a number of problems, including air and water pollution."

So far, most nitrogen studies have focused on problems such as losses in biodiversity, increased acid rain and changes in coastal ocean ecology that include oxygen-poor "dead zones" like those seen in the Gulf of Mexico.

However, excess nitrogen also can be a health concern for humans in many ways, including respiratory ailments, heart disease and several cancers, said Townsend, who also is an assistant professor in CU-Boulder's ecology and evolutionary biology department.

"Ecological feedbacks to excess nitrogen can inhibit crop growth, increase allergenic pollen production and potentially affect the dynamics of several vec
'"/>


12-Jun-2003


Page: 1 2 3

Related biology news :

1. Changing one gene launches new fly species
2. Changing the face of biology
3. Changing focus of traditional hospital rounds improves patient care
4. Changing fish body shapes give clues to environmental factors
5. Relationships in a Changing World -- call for papers
6. Changing colors in mice
7. Changing childrens diets today could reduce bone problems 70 years from now
8. If You Cant Stop Polluting, Try Changing The Weather Instead
9. USGS Finds Sea Otters At Risk From Killer Whales In A Changing Ocean
10. Corn Rootworm Changing Behavior, Posing New Threat To Crops
11. Changing Continental Runoff Patterns Could Change Ocean Circulation

Post Your Comments:
(Date:3/17/2015)... Minn. , March 17, 2015 ... technology company specializing in clinical study management systems, ... be in attendance at ARENA,s Outsourcing in Clinical ... NC.  This event provides an excellent forum for ... easy-to-use, flexible and affordable software-as-a-service (SaaS) eClinical technology ...
(Date:3/12/2015)... , March 12, 2015 The mascots of ... Children,s Hospital, part of Wake Forest Baptist Medical Center. ... for the 2015 ACC Men,s Basketball Tournament. Young patients ... them and getting their autographs. Brenner Children,s ... It is the only children,s hospital in northwest ...
(Date:3/10/2015)... 2015  Continuing its 167-year history of offering the ... The Eye Scanning Password Authenticator , a device ... secure websites or sensitive data. Employing the ... borders, the device has a small camera that scans ... iris, converting them into an encrypted ID that cannot ...
Breaking Biology News(10 mins):Connect With MedNet Solutions At Outsourcing In Clinical Trials Southeast 2Hammacher Schlemmer Introduces The Eye Scanning Password Authenticator 2
(Date:3/25/2015)... 2015 /PRNewswire/ - SQI Diagnostics Inc. ("SQI" or the "Company") ... of recent discussions with certain shareholders representing approximately 45% ... after dealing with certain matters including the appointment of ... on March 26, 2015 (the "Meeting") it intends to ... will take place when the Meeting reconvenes. The Meeting ...
(Date:3/25/2015)... 25, 2015  S&P Capital IQ (MHFI) announced ... Report coverage on Abattis Bioceuticals Corp . ... is a specialty biotechnology company with capabilities through ... marketing proprietary ingredients, bio-similar compounds, patented equipment and ... North America . The company seeks to ...
(Date:3/25/2015)... , CAMBRIDGE, Mass. and ... NextCODE, which provides comprehensive capabilities for using the genome to ... on their publication of the largest studies of whole-genome data ... online in Nature Genetics – are ... sequence variation, authored by a team of deCODE scientists led ...
(Date:3/25/2015)... CA (PRWEB) March 25, 2015 ... for Novel Mechanism of Action in Neuromuscular Diseases ... 2015 – Cytokinetics, Incorporated (Nasdaq: CYTK) announced the ... skeletal muscle troponin activator tirasemtiv in the journal ... Phase IIa “Evidence of Effect” or hypothesis-generating clinical ...
Breaking Biology Technology:SQI Diagnostics Inc. Announces New Nominees to SQI Diagnostics Board and Adjournment of Meeting 2SQI Diagnostics Inc. Announces New Nominees to SQI Diagnostics Board and Adjournment of Meeting 3SQI Diagnostics Inc. Announces New Nominees to SQI Diagnostics Board and Adjournment of Meeting 4SQI Diagnostics Inc. Announces New Nominees to SQI Diagnostics Board and Adjournment of Meeting 5S&P Capital IQ Initiates Coverage on Abattis Bioceuticals Corp. in S&P Capital IQ Factual Stock Reports 2S&P Capital IQ Initiates Coverage on Abattis Bioceuticals Corp. in S&P Capital IQ Factual Stock Reports 3S&P Capital IQ Initiates Coverage on Abattis Bioceuticals Corp. in S&P Capital IQ Factual Stock Reports 4S&P Capital IQ Initiates Coverage on Abattis Bioceuticals Corp. in S&P Capital IQ Factual Stock Reports 5Landmark deCODE Studies Demonstrate the Power of Truly Big Genomics for Improving Medicine Worldwide 2Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 2Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 3Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 4Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 5Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 6
Cached News: